Resources from the same session
2522 - Apalutamide (APA) and Overall Survival (OS) in Patients (pts) With Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): Updated Results From the Phase 3 SPARTAN Study
Presenter: Matthew Smith
Session: Proffered Paper – Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
2348 - Docetaxel for hormone-naïve prostate cancer: results from long-term follow-up of metastatic (M1) patients in the STAMPEDE randomised trial (NCT00268476) and sub-group analysis by metastatic burden
Presenter: Nicholas James
Session: Proffered Paper – Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
Proffered Paper – Genitourinary tumours, prostate - Invited Discussant 843O and 844O
Presenter: Karim Fizazi
Session: Proffered Paper – Genitourinary tumours, prostate
Resources:
Slides
Webcast
5191 - Timing of Radiotherapy (RT) After Radical Prostatectomy (RP): First Results from the RADICALS RT Randomised Controlled Trial (RCT) [NCT00541047]
Presenter: Chris Parker
Session: Proffered Paper – Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
2508 - Adjuvant or salvage radiotherapy for the treatment of localised prostate cancer? A prospectively planned aggregate data meta-analysis
Presenter: Claire Vale
Session: Proffered Paper – Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast